The pediatric costs of strategies for minimizing the risk of early-onset group B streptococcal disease.
O'Brien
K L
KL
Whitney
C G
CG
Schuchat
A
A
D006801:Humans; D007231:Infant, Newborn; D013290:Streptococcal Infections / Q000191:economics* / Q000517:prevention & control*; D013292:Streptococcus agalactiae / Q000472:pathogenicity*